KEY PRODUCTS
Pfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.
01 1Pfizer CentreOne
01 1HEPARIN SODIUM USP
01 1U.S.A
01 1Active
01 1Complete
Pfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.
GDUFA
DMF Review : Complete
Rev. Date : 2020-09-15
Pay. Date : 2020-09-14
DMF Number : 2712
Submission : 1976-08-03
Status : Active
Type : II
20
Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Pfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.
One of their notable products is HEPARIN SODIUM USP, with a corresponding US DMF Number 2712.
Remarkably, this DMF maintains an Active status since its submission on August 03, 1976, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 15, 2020, and payment made on September 14, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
